The serum level of fibroblast growth factor-23 and calcium-phosphate homeostasis in obese perimenopausal women

International Journal of Endocrinology

Volumn 2011, Issue , 2011, Pages

  Holecki, M ^a   Chudek, J ^a   Wiecek A ^a   Titz Bober, M ^a   Dulawa J ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; FIBROBLAST GROWTH FACTOR 23; INTACT FIBROBLAST GROWTH FACTOR 23; INTACT PARATHYROID HORMONE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BODY MASS; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCIUM HOMEOSTASIS; CLIMACTERIUM; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT CONTENT; FEMALE; FEMUR; FEMUR NECK; GLOMERULUS FILTRATION RATE; HUMAN; LUMBAR SPINE; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROXIMAL FEMUR;

EID: 84855598683     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2011/707126     Document Type: Article

References (28)

1. Tremollieres F. A., Pouilles J. M., Ribot C., Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women Journal of Clinical Endocrinology and Metabolism 1993 77 3 683 686 (Pubitemid 23298648)
2. Glass A. R., Endocrine aspects of obesity Medical Clinics of North America 1989 73 1 139 160 (Pubitemid 19032519)
3. Holecki M., Zahorska-Markiewicz B., Nieszporek T., Selected parameters of bone turnover in obese perimenopausal women Annals Academy of Medicine 2006 60 2 186 191
4. Holecki M., Zahorska-Markiewicz B., Nieszporek T., Olszanecka- Glinianowicz M., Mizia-Stec K., Zak-Goab A., Koceak P., Frylewicz-Moska A., Wiecek A., Impact of the mass-reductive therapy with orlistat on 25-(OH)-D3 and PTH concentration in sera of obese, menopausal women Endokrynologia Polska 2005 56 3 240 245
5. Andersen T., McNair P., Fogh-Andersen N., Increased parathyroid hormone as a consequence of changed complex binding of plasma calcium in morbid obesity Metabolism: Clinical and Experimental 1986 35 2 147 151 (Pubitemid 16160932)
6. Mosekilde L., Melsen F., Hessov I., Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity Gut 1980 21 7 624 631 (Pubitemid 10018353)
7. Ostrowska Z., Zwirska-Korczala K., Buntner B., Pardela M., Drozdz M., Assessment of bone metabolism in obese women Endocrine Regulations 1998 32 4 177 181 (Pubitemid 128528258)
8. Liel Y., Ulmer E., Shary J., Hollis B. W., Bell N. H., Low circulating vitamin D in obesity Calcified Tissue International 1988 43 4 199 201
9. Yamashita T., Yoshioka M., Itoh N., Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain Biochemical and Biophysical Research Communications 2000 277 2 494 498
10. Mejhert N., Galitzky J., Pettersson A. T., Bambace C., Blomqvist L., Bouloumié A., Frayn K. N., Dahlman I., Arner P., Rydén M., Mapping of the fibroblast growth factors in human white adipose tissue Journal of Clinical Endocrinology and Metabolism 2010 95 5 2451 2457
11. Liu S., Zhou J., Tang W., Jiang X., Rowe D. W., Quarles L. D., Pathogenic role of Fgf23 in Hyp mice American Journal of PhysiologyEndocrinology and Metabolism 2006 291 1 E38 E49
12. Feng J. Q., Ward L. M., Liu S., Lu Y., Xie Y., Yuan B., Yu X., Rauch F., Davis S. I., Zhang S., Rios H., Drezner M. K., Quarles L. D., Bonewald L. F., White K. E., Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism Nature Genetics 2006 38 11 1310 1315 (Pubitemid 44646294)
13. Samadfam R., Richard C., Nguyen-Yamamoto L., Bolivar I., Goltzman D., Bone formation regulates circulating concentrations of fibroblast growth factor 23 Endocrinology 2009 150 11 4835 4845
14. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y., Fujita T., Nakahara K., Fukumoto S., Yamashita T., FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis Journal of Bone and Mineral Research 2004 19 3 429 435 (Pubitemid 38787398)
15. Mirza M. A., Alsi J., Hammarstedt A., Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly 236 individuals Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1 219 227
16. Stevens L. A., Claybon M. A., Schmid C. H., Chen J., Horio M., Imai E., Nelson R. G., Van Deventer M., Wang H. Y., Zuo L., Zhang Y., Levey A. S., Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities Kidney International 2009 150 9 604 612
17. Mirza M. A., Karlsson M. K., Mellstrm D., Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men Journal of Bone and Mineral Research 2011 26 4 857 864
18. Yu X., Sabbagh Y., Davis S. I., Demay M. B., White K. E., Genetic dissection of phosphate- and vitamin D-mediated regulation of circulating Fgf23 concentrations Bone 2005 36 6 971 977 (Pubitemid 40797997)
19. Antoniucci D. M., Yamashita T., Portale A. A., Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men Journal of Clinical Endocrinology and Metabolism 2006 91 8 3144 3149 (Pubitemid 44271770)
20. Kawata T., Imanishi Y., Kobayashi K., Miki T., Arnold A., Inaba M., Nishizawa Y., Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism Journal of the American Society of Nephrology 2007 18 10 2683 2688 (Pubitemid 47531195)
21. Krajisnik T., Bjrklund P., Marsell R., Ljunggren Osten O.., kerstrm G., Jonsson K. B., Westin G., Larsson T. E., Fibroblast growth factor-23 regulates parathyroid hormone and 1 -hydroxylase expression in cultured bovine parathyroid cells Journal of Endocrinology 2007 195 1 125 131 (Pubitemid 350056006)
22. Ben-Dov I. Z., Galitzer H., Lavi-Moshayoff V., Goetz R., Kuro-o M., Mohammadi M., Sirkis R., Naveh-Many T., Silver J., The parathyroid is a target organ for FGF23 in rats Journal of Clinical Investigation 2007 117 12 4003 4008 (Pubitemid 350224109)
23. Burnett S. A. M., Gunawardene S. C., Bringhurst F. R., Jppner H., Lee H., Finkelstein J. S., Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women Journal of Bone and Mineral Research 2006 21 8 1187 1196 (Pubitemid 44128331)
24. O'Donnell M. P., Kasiske B. L., Cleary M. P., Keane W. F., Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies The Journal of Laboratory and Clinical Medicine 1985 106 5 605 610
25. Kasiske B. L., Napier J., Glomerular sclerosis in patients with massive obesity American Journal of Nephrology 1985 5 1 45 50 (Pubitemid 15195137)
26. Wang H., Yoshiko Y., Yamamoto R., Minamizaki T., Kozai K., Tanne K., Aubin J. E., Maeda N., Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro Journal of Bone and Mineral Research 2008 23 6 939 948 (Pubitemid 351768812)
27. Holecki M., Zahorska-Markiewicz B., Chudek J., Changes in bone mineral density and markers of bone turnover in obese women after short weight loss treatment during five-year observation Polish Archives of Internal Medicine 2010 120 7-8 248 254
28. Marsell R., Mirza M. A. I., Mallmin H., Karlsson M., Mellstrm D., Orwoll E., Ohlsson C., Jonsson K. B., Ljunggren O.., Larsson T. E., Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men Osteoporosis International 2009 20 7 1167 1173